Mawson Infrastructure Group Signs First Hosting Customers

Adds diversified revenue stream SYDNEY--(BUSINESS WIRE)--Mawson Infrastructure Group (OTCQB:MIGI), a Digital Infrastructure provider with diversified…

Bio-Thera Solutions Initiates Phase III Clinical Trial for BAT2506, a Proposed Biosimilar of Simponi® (Golimumab)

GUANGZHOU, China--(BUSINESS WIRE)--#autoimmunedisease--Bio-Thera Solutions, Ltd. (688177.SH), a commercial-stage pharmaceutical company, today announced that dosing has…

Bio-Thera Solutions Initiates Phase III Clinical Trial for BAT2506, a Proposed Biosimilar of Simponi® (Golimumab)

GUANGZHOU, China--(BUSINESS WIRE)--#autoimmunedisease--Bio-Thera Solutions, Ltd. (688177.SH), a commercial-stage pharmaceutical company, today announced that dosing has…

Self Esteem Brands Acquires Digital Nutrition Coaching Brand Stronger U

Leading nutrition-based health coaching service joins SEB as it evolves to meet growing consumer demand…

Self Esteem Brands Acquires Digital Nutrition Coaching Brand Stronger U

Leading nutrition-based health coaching service joins SEB as it evolves to meet growing consumer demand…

Boyd Corporation Expands Global Footprint With State-of-the-Art Facility in Vietnam

Boyd Expands High Volume Automated Manufacturing Capacity in Asia Pacific with New Facility in Bac…

Boyd Corporation Expands Global Footprint With State-of-the-Art Facility in Vietnam

Boyd Expands High Volume Automated Manufacturing Capacity in Asia Pacific with New Facility in Bac…

Twist Bioscience Begins Shipping of Synthetic RNA Controls for Kappa (B.1.617.1) SARS-CoV-2 Variants for Development of Accurate Tests

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed…

IASO Biotherapeutics and Innovent Biologics to Present Updated Data from its Anti-BCMA CAR-T Therapy in Relapsed/Refractory Multiple Myeloma at European Hematology Association (EHA) Congress

PLEASANTON, Calif. & NANJING, China--(BUSINESS WIRE)--#AutoimmuneDiseases--IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in…

Cushman & Wakefield Voted Hong Kong’s Second Most Attractive Employer in Randstad Employer Brand Survey

HONG KONG SAR - Media OutReach - 8 June 2021 - Cushman & Wakefield has…